Functional screening for p53 activity upon silencing of putative p53 inhibitors in cancer cells using siRNA or shRNA molecules should identify active inhibitors, and the same molecules would then be used together with an oncolytic adenovirus to achieve effective cancer cell killing. This evidence concerns the gene TP53 and cancer.